 Presynaptic Terminals
"Presynaptic Terminals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The distal terminations of axons which are specialized for the release of neurotransmitters. Also included are varicosities along the course of axons which have similar specializations and also release transmitters. Presynaptic terminals in both the central and peripheral nervous systems are included.
| Descriptor ID |
D017729
|
| MeSH Number(s) |
A08.675.542.145.750 A08.850.700 A11.284.149.165.420.780.700 A11.671.137.750 A11.671.501.145.750
|
| Concept/Terms |
Presynaptic Terminals- Presynaptic Terminals
- Presynaptic Terminal
- Terminal, Presynaptic
- Terminals, Presynaptic
- Synaptic Terminals
- Synaptic Terminal
- Terminal, Synaptic
- Terminals, Synaptic
- Synaptic Boutons
- Bouton, Synaptic
- Boutons, Synaptic
- Synaptic Bouton
- Axon Terminals
- Axon Terminal
- Terminal, Axon
- Terminals, Axon
- Nerve Endings, Presynaptic
- Ending, Presynaptic Nerve
- Endings, Presynaptic Nerve
- Nerve Ending, Presynaptic
- Presynaptic Nerve Ending
- Presynaptic Nerve Endings
|
Below are MeSH descriptors whose meaning is more general than "Presynaptic Terminals".
Below are MeSH descriptors whose meaning is more specific than "Presynaptic Terminals".
This graph shows the total number of publications written about "Presynaptic Terminals" by people in this website by year, and whether "Presynaptic Terminals" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 2000 | 0 | 2 | 2 | | 2001 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 2003 | 0 | 1 | 1 | | 2004 | 0 | 1 | 1 | | 2005 | 1 | 2 | 3 | | 2008 | 3 | 2 | 5 | | 2009 | 3 | 3 | 6 | | 2010 | 1 | 2 | 3 | | 2011 | 2 | 0 | 2 | | 2012 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2014 | 3 | 1 | 4 | | 2015 | 0 | 1 | 1 | | 2016 | 2 | 2 | 4 | | 2017 | 1 | 0 | 1 | | 2018 | 0 | 2 | 2 | | 2019 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 | | 2021 | 3 | 0 | 3 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Presynaptic Terminals" by people in Profiles.
-
Burlingham SR, Wong NF, Peterkin L, Lubow L, Dos Santos Passos C, Benner O, Ghebrial M, Cast TP, Xu-Friedman MA, S?dhof TC, Chanda S. Induction of synapse formation by de novo neurotransmitter synthesis. Nat Commun. 2022 06 01; 13(1):3060.
-
Garcia JD, Gookin SE, Crosby KC, Schwartz SL, Tiemeier E, Kennedy MJ, Dell'Acqua ML, Herson PS, Quillinan N, Smith KR. Stepwise disassembly of GABAergic synapses during pathogenic excitotoxicity. Cell Rep. 2021 12 21; 37(12):110142.
-
Boxer EE, Seng C, Lukacsovich D, Kim J, Schwartz S, Kennedy MJ, F?ldy C, Aoto J. Neurexin-3 defines synapse- and sex-dependent diversity of GABAergic inhibition in ventral subiculum. Cell Rep. 2021 12 07; 37(10):110098.
-
Reva M, DiGregorio DA, Grebenkov DS. A first-passage approach to diffusion-influenced reversible binding and its insights into nanoscale signaling at the presynapse. Sci Rep. 2021 03 08; 11(1):5377.
-
Hark TJ, Rao NR, Castillon C, Basta T, Smukowski S, Bao H, Upadhyay A, Bomba-Warczak E, Nomura T, O'Toole ET, Morgan GP, Ali L, Saito T, Guillermier C, Saido TC, Steinhauser ML, Stowell MHB, Chapman ER, Contractor A, Savas JN. Pulse-Chase Proteomics of the App Knockin Mouse Models of Alzheimer's Disease Reveals that Synaptic Dysfunction Originates in Presynaptic Terminals. Cell Syst. 2021 02 17; 12(2):141-158.e9.
-
Held RG, Liu C, Ma K, Ramsey AM, Tarr TB, De Nola G, Wang SSH, Wang J, van den Maagdenberg AMJM, Schneider T, Sun J, Blanpied TA, Kaeser PS. Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. Neuron. 2020 08 19; 107(4):667-683.e9.
-
Riggs LM, Aracava Y, Zanos P, Fischell J, Albuquerque EX, Pereira EFR, Thompson SM, Gould TD. (2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism. Neuropsychopharmacology. 2020 01; 45(2):426-436.
-
Tyagi S, Bendrick TR, Filipova D, Papadopoulos S, Bannister RA. A mutation in CaV2.1 linked to a severe neurodevelopmental disorder impairs channel gating. J Gen Physiol. 2019 06 03; 151(6):850-859.
-
Crosby KC, Gookin SE, Garcia JD, Hahm KM, Dell'Acqua ML, Smith KR. Nanoscale Subsynaptic Domains Underlie the Organization of the Inhibitory Synapse. Cell Rep. 2019 03 19; 26(12):3284-3297.e3.
-
Tabuchi S, Gilmer JI, Purba K, Person AL. Pathway-Specific Drive of Cerebellar Golgi Cells Reveals Integrative Rules of Cortical Inhibition. J Neurosci. 2019 02 13; 39(7):1169-1181.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|